子痫前期

National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. January 2011 [internet publication].

• 全文

Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002 Sep;2(9):656-63. [Erratum in: Nat Rev Immunol 2002 Dec;2(12):975.]

• 摘要

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 Mar 12;330(7491):565.

• 全文
• 摘要

National Institute for Health and Care Excellence. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio). December 2018 [internet publication].

• 全文

Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995 Jun 10;345(8963):1455-63.

• 摘要

1.  American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122-31.

• 全文
• 摘要

2.  Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014 Apr;4(2):97-104.

• 摘要

3.  National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. January 2011 [internet publication].

• 全文

4.  US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for preeclampsia: US Preventive Services Task Force recommendation statement. JAMA. 2017 Apr 25;317(16):1661-7.

• 全文
• 摘要

5.  Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013 Oct;71(suppl 1):S18-25.

• 全文
• 摘要

6.  Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005 Jul;112(7):875-80.

• 全文
• 摘要

7.  Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. Int J Womens Health. 2017 May 17;9:353-7.

• 全文
• 摘要

8.  Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095.

• 全文
• 摘要

9.  Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002 Sep;2(9):656-63. [Erratum in: Nat Rev Immunol 2002 Dec;2(12):975.]

• 摘要

10.  Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 Mar 12;330(7491):565.

• 全文
• 摘要

11.  Brew O, Sullivan MH, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS One. 2016 Aug 25;11(8):e0161504.

• 全文
• 摘要

12.  Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 2018 Feb 28;7:242.

• 全文
• 摘要

13.  Smith TA, Kirkpatrick DR, Kovilam O, et al. Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia. Expert Rev Clin Immunol. 2015;11(9):1055-63.

• 全文
• 摘要

14.  de Haas S, Ghossein-Doha C, van Kuijk SM, et al. Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017 Feb;49(2):177-87.

• 摘要

15.  Deen ME, Ruurda LG, Wang J, et al. Risk factors for preeclampsia in multiparous women: primipaternity versus the birth interval hypothesis. J Matern Fetal Neonatal Med. 2006 Feb;19(2):79-84.

• 摘要

16.  Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000 Sep;21(7):597-602.

• 摘要

17.  GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet. 2005 Jul;77(1):127-31.

• 全文
• 摘要

18.  Taravati A, Tohidi F, Moniri M, et al. Catechol-O-methyltransferase gene polymorphism (Val158Met) and development of pre-eclampsia. Arch Med Res. 2017 Feb;48(2):180-6.

• 摘要

19.  Poorolajal J, Jenabi E. The association between body mass index and preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2016 Nov;29(22):3670-6.

• 摘要

20.  Spradley FT. Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2017 Jan 1;312(1):R5-12.

• 全文
• 摘要

21.  Centre for Maternal and Child Enquiries (CMACE). Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011 Mar;118(suppl 1):1-203.

• 全文
• 摘要

22.  DoPierala AL, Bhatta S, Raja EA, et al. Obstetric consequences of subfertility: a retrospective cohort study. BJOG. 2016 Jul;123(8):1320-8.

• 摘要

23.  Tarlatzi TB, Imbert R, Alvaro Mercadal B, et al. Does oocyte donation compared with autologous oocyte IVF pregnancies have a higher risk of preeclampsia? Reprod Biomed Online. 2017 Jan;34(1):11-8.

• 全文
• 摘要

24.  Walker JJ. Pre-eclampsia. Lancet. 2000 Oct 7;356(9237):1260-5.

• 摘要

25.  Yu HF, Chen HS, Rao DP, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016 Dec;95(51):e4863.

• 全文
• 摘要

26.  Palmer SK, Moore LG, Young D, et al. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol. 1999 May;180(5):1161-8.

• 摘要

27.  Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug 17;377(7):613-22.

• 全文
• 摘要

28.  Gan J, He H, Qi H. Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians: a systematic review and meta-analysis. Hypertens Pregnancy. 2016 Aug;35(3):426-35.

• 摘要

29.  Roberge S, Villa P, Nicolaides K, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141-6.

• 全文
• 摘要

30.  Barakat R, Pelaez M, Cordero Y, et al. Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol. 2016 May;214(5):649;e1-8.

• 摘要

31.  Villar J, Abdel-Aleem H, Merialdi M, et al; World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006 Mar;194(3):639-49.

• 全文
• 摘要

32.  Hofmeyr GJ, Manyame S. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2017;(9):CD011192.

• 全文
• 摘要

33.  Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988 Apr;158(4):892-8.

• 摘要

34.  Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):e1-29.

• 全文
• 摘要

35.  National Institute for Health and Care Excellence. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio). December 2018 [internet publication].

• 全文

36.  Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 19 Apr 1. pii: S0140-6736(18)33212-4.

• 全文
• 摘要

37.  Iacobucci G. NHS to roll out blood tests for pre-eclampsia after positive study results. BMJ. 2019 Apr 2;365:l1543.

• 摘要

38.  Eastwood KA, Patterson C, Hunter AJ, et al. Evaluation of the predictive value of placental vascularisation indices derived from 3-dimensional power Doppler whole placental volume scanning for prediction of pre-eclampsia: a systematic review and meta-analysis. Placenta. 2017 Mar;51:89-97.

• 摘要

39.  Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016 Jan 7;374(1):13-22.

• 全文
• 摘要

40.  Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013 Nov 5;128(19):2121-31.

• 全文
• 摘要

41.  Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011 Apr;66(4):225-39.

• 摘要

42.  Skråstad RB, Hov GG, Blaas HG, et al. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms. BJOG. 2015 Dec;122(13):1781-8.

• 全文
• 摘要

43.  van Baaren GJ, Broekhuijsen K, van Pampus MG, et al. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). BJOG. 2017 Feb;124(3):453-61.

• 全文
• 摘要

44.  Publications Committee, Society for Maternal-Fetal Medicine; Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011 Sep;205(3):191-8.

• 全文
• 摘要

45.  Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-501.

• 摘要

46.  Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017;(1):CD009273.

• 全文
• 摘要

47.  Hein HA. Cardiorespiratory arrest with laryngeal oedema in pregnancy-induced hypertension. Can Anaesth Soc J. 1984 Mar;31(2):210-2.

• 摘要

48.  Committee on Obstetric Practice. Committee opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol. 2011 Dec;118(6):1465-8.

• 摘要

49.  Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7.

• 全文
• 摘要

50.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995 Jun 10;345(8963):1455-63.

• 摘要

51.  Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96.

• 摘要

52.  McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.

• 全文
• 摘要

53.  Smith RN, Nolan JP. Central venous catheters. BMJ. 2013 Nov 11;347:f6570.

• 摘要

54.  Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.

55.  Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2015 [internet publication].

• 全文

56.  Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78.

• 摘要

57.  Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91.

• 全文

58.  Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.

• 全文

59.  Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4.

• 全文

60.  Conrad KP. G-protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention. Hum Reprod Update. 2016 Sep;22(5):647-64.

• 全文
• 摘要

61.  Paauw ND, Terstappen F, Ganzevoort W, et al. Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure. Hypertension. 2017 Nov;70(5):998-1006.

• 摘要

62.  Sibley CP. Treating the dysfunctional placenta. J Endocrinol. 2017 Aug;234(2):R81-97.

• 全文
• 摘要

63.  Heida KY, Bots ML, de Groot CJ, et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol. 2016 Nov;23(17):1863-79.

• 摘要

64.  Wang Z, Wang Z, Wang L, et al. Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis. Endocrine. 2017 Mar;55(3):809-21.

• 摘要

65.  Benschop L, Duvekot JJ, Versmissen J, et al. Blood pressure profile 1 year after severe preeclampsia. Hypertension. 2018 Mar;71(3):491-8.

• 摘要

66.  Miller EC, Gatollari HJ, Too G, et al. Risk factors for pregnancy-associated stroke in women with preeclampsia. Stroke. 2017 Jul;48(7):1752-9.

• 全文
• 摘要

67.  Dodd JM, McLeod A, Windrim RC, et al. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2013;(7):CD006780.

• 全文
• 摘要

68.  Roberge S, Demers S, Nicolaides KH, et al. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2016 May;47(5):548-53.

• 全文
• 摘要